INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO-Reference-Cited by-同舟云学术

INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO

Published:2002-01 Issue:1 Volume:167 Page:357-363
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BÖHLE A.¹,JURCZOK A.¹,ARDELT P.¹,WULF T.¹,ULMER A.J.¹,JOCHAM D.¹,BRANDAU S.¹

Affiliation:

1. From the Department of Urology, Medical University of Lübeck, Lübeck and Department of Immunology and Cell Biology, Borstel Research Center, Borstel, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference59 articles.

1. Prognostic factors in superficial bladder cancer;Aso;Prog Clin Biol Res,1986

2. The management of superficial bladder cancer;Soloway;Cancer,1980

3. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases;Lutzeyer;J Urol,1982

4. Superficial bladder cancer: progression and recurrence. National Bladder Cancer Collaborative Group A;Heney;J Urol,1983

5. Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping;Koss;Urology,1977

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term prevention of bladder cancer progression by alpha1‐oleate alone or in combination with chemotherapy;International Journal of Cancer;2023-04-03

2. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ);European Urology;2022-01

3. Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence;Anti-Cancer Agents in Medicinal Chemistry;2021-03

4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update;European Urology;2019-11

5. Nanomedicines for Intravesical Chemotherapy in Bladder Cancer;Current Pharmaceutical Design;2019-06-03